Identification, classification, and expression ofRAGEgene splice variants
- 18 December 2007
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 22 (5), 1572-1580
- https://doi.org/10.1096/fj.07-9909com
Abstract
The receptor for advanced glycation end-products (RAGE) is a single-transmembrane, mul- tiligand receptor of the immunoglobulin superfamily. RAGE up-regulation is implicated in numerous patho- logical states including vascular disease, diabetes, can- cer, and neurodegeneration. The understanding of the regulation of RAGE is important in both disease patho- genesis and normal homeostasis. Here, we demonstrate the characterization and identification of human RAGE splice variants by analysis of RAGE cDNA from tissue and cells. We identified a vast range of splice forms that lead to changes in the protein coding region of RAGE, which we have classified according to the Human Gene Nomenclature Committee (HGNC). These resulted in protein changes in the ligand-binding domain of RAGE or the removal of the transmembrane domain and cytosolic tail. Analysis of splice variants for premature termination codons reveals50% of identified variants are targeted to the nonsense-mediated mRNA decay pathway. Expression analysis revealed the RAGE_v1 variant to be the primary secreted soluble isoform of RAGE. Taken together, identification of functional splice variants of RAGE underscores the biological diversity of the RAGE gene and will aid in the under- standing of the gene in the normal and pathological state. —Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., Schmidt, A. M. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22, 1572-1580 (2008)Keywords
Funding Information
- U.S. Public Health Service
This publication has 28 references indexed in Scilit:
- Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brainNeuroscience Letters, 2004
- Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cellsMolecular Immunology, 2004
- Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injuryBiochemical Journal, 2003
- Guidelines for Human Gene NomenclatureGenomics, 2002
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for AmphoterinPublished by Elsevier BV ,1995